Perry is a current Kenvue director and seasoned consumer products and brand strategist with more than 30 years of experience.

Kenvue (NYSE:KVUE) recently experienced a 2% price increase over the past week, a move that coincides with notable executive changes. The replacement of the CEO with Kirk L. Perry as interim CEO, ...

Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the ...

Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.

Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...

Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic ...

All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director ...

Kenvue Inc. (NYSE: KVUE) is one of the stocks on Jim Cramer’s radar. During the episode, Cramer discussed the company’s ...

Crypto-sensitive stocks rose, as [bitcoin prices rallied to another high]( ...

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...